# Role of IGFBP3 in Neonatal Heart Regeneration

> **NIH NIH K08** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2024 · $75,600

## Abstract

Project Summary/Abstract
 This is for an administrative supplement for a K08 award for Dr. Shah Ali, MD, an Assistant Professor in
Cardiology at the Columbia University Medical Center. He has completed residency training in Internal Medicine
at the University of California San Francisco and fellowship training in Cardiology at UTSW.
 The research in this proposal will be conducted in the laboratory of Dr. Steven Marx, a leading expert in
the field of cardiomyocyte and ion channel biology and an ideal mentor with significant training experience. In
addition, an Advisory Committee composed of Columbia-based mentors as well as Dr. Hesham Sadek will
provide biannual constructive criticism of data, hypotheses, and proposed experiments in a written manner as
well as career guidance and development.
 The proposal described herein will investigate the molecular mechanisms of neonatal heart regeneration
in mice with an aim at translating these findings to humans to generate novel therapies to treat heart diseases.
Although the mammalian heart is known to be a mostly quiescent organ whose primary parenchymal cell – the
cardiomyocyte – is cell cycle-arrested in adults, recent pioneering studies from the laboratory of Dr. Sadek have
characterized a phenomenon of complete cardiac regeneration in neonatal mice. After resection of the ventricular
apex or surgically-induced myocardial infarction (MI), mice younger than one week of age exhibit complete
cardiomyocyte renewal, in stark contrast to adult mice that develop a fibrotic scar due to failure to achieve
meaningful cardiomyogenesis. A fate-mapping approach showed that existing cardiomyocytes divide to generate
new cardiomyocytes after neonatal injuries.
 Based on the above findings, we hypothesized that there are cardiotropic factors within the young mouse
heart that elicit the robust cardiomyocyte proliferation after neonatal MI. Our preliminary data identifies insulin-
like growth factor binding protein, IGFBP3, as a cardiomyocyte mitogen that enables cardiomyocyte division.
Intriguingly, this factor is not expressed in the heart in the absence of injury or during development, suggesting
that it is part of a specific injury-induced signaling pathway. The specific aims propose to: 1) identify and
characterize the cell that secretes IGFBP3 in response to injury, 2) determine whether IGFBP3 is necessary for
neonatal regeneration and/or sufficient to promote cardiomyocyte renewal after adult MI, and 3) determine
whether IGFBP3 utilizes IGF signaling to stimulate cardiomyocyte division.
 Ultimately, the training and research plan outlined here will support Dr. Ali as he achieves independence
as a physician-scientist-cardiologist. As an independent PI, Dr. Ali will study the mechanisms that mediate
neonatal heart regeneration to inform the development of novel therapeutics for adult heart disease, a logical
extension of his K08 proposal.

## Key facts

- **NIH application ID:** 11022013
- **Project number:** 3K08HL153788-04S1
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Shah Rukh Ali
- **Activity code:** K08 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $75,600
- **Award type:** 3
- **Project period:** 2022-04-01 → 2025-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11022013

## Citation

> US National Institutes of Health, RePORTER application 11022013, Role of IGFBP3 in Neonatal Heart Regeneration (3K08HL153788-04S1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/11022013. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*